Intelligence / Healthtech / New Clinical Trials / Pfizer
Clinicaltrial registered28 Oct 2026
Pfizer
28 Oct 2026: Trial registered · A Study to Learn About COVID-19 Antivirals in People With SARS-CoV-2 Infection From 2023-2026. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 28 Oct 2026
- Title
- A Study to Learn About COVID-19 Antivirals in People With SARS-CoV-2 Infection From 2023-2026
- Conditions
- COVID-19 SARS-CoV-2 Infection
- Study Type
- Observational
- Status
- Active Not Recruiting
- Countries
- United States
- Country
- United States
- Reference
- NCT07900139
- Location
- United States
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Pfizer
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
Across AOS Research
Other records for Pfizer in our registers.
12 NovPfizertrial registered · HealthtechClinical12 NovPfizertrial registered · HealthtechClinical12 NovPfizertrial registered · HealthtechClinical9 NovPfizertrial registered · HealthtechClinical9 NovPfizertrial registered · HealthtechClinical5 NovPfizertrial registered · HealthtechClinical4 NovPfizertrial registered · HealthtechClinical2 NovPfizertrial registered · HealthtechClinical30 OctPfizertrial registered · HealthtechClinical29 OctPfizertrial registered · HealthtechClinical27 OctPfizertrial registered · HealthtechClinical27 OctPfizertrial registered · HealthtechClinical
More from United States
New Clinical Trials
18 NovBrocShot Inctrial registered · A Clinical Trial to Evaluate the Effects of Broc Shot Capsules on Skin Appearance and Comfort in Adults With Reactive, Blemish-Prone, or Hormonally Affected SkinClinical18 NovCoherus Oncology, Inc.trial registered · A Study of Tagmokitug in Combination With Other Treatments in Participants With Advanced or Metastatic Solid TumorsClinical18 NovCugene Inc.trial registered · A Phase I Dose-Escalation Study of CUG279 in Participants With Select Advanced or Metastatic Solid TumorsClinical18 NovDriscoll'strial registered · A Clinical Study to Evaluate the Effects of Driscoll's Raspberries and Driscoll's Blackberries on Postprandial Glycemic Response, Satiety, and Consumer Appeal in Healthy AdultsClinical18 NovEpetometrial registered · A Clinical Trial to Evaluate the Effects of the Synbiotic Dual Cap® on Gastrointestinal Comfort in Adults Initiating GLP-1 or Dual-Incretin Therapy for Weight Loss.Clinical18 NovEtta Vitatrial registered · A Clinical Trial to Evaluate the Effects of a Supplement on Appetite, Gut Health, and Blood SugarClinical
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.